SLC5A2 and chronic kidney disease: ECW/TBW was shown to be independently associated with coronary artery calcification in patients with chronic kidney disease [30], and ECW/TBW could predict the body fluid response to the SGLT2 inhibitor dapagliflozin and assess all-cause mortality, nutrition status and body composition in patients with diabetic kidney disease [31].